España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Cue Biopharma
CUE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.779600
0.04
5.00%
Pre-Market: 5:33 PM EDT
15 minutes delayed
Get Report
Comment
Cue Biopharma (CUE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cue Biopharma (NASDAQ:CUE) Stock
Cue Biopharma Stock (NASDAQ: CUE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 04, 2024
Cue Biopharma Presents Updated Data From Phas...
Benzinga Newsdesk
Friday, May 10, 2024
Cue Biopharma shares are trading lower. The c...
Benzinga Newsdesk
Thursday, May 09, 2024
Cue Biopharma Q1 2024 Adj EPS $(0.25) Beats $...
Benzinga Newsdesk
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, April 09, 2024
Forecasting The Future: 4 Analyst Projections For Cue Biopharma
Benzinga Insights
Stifel Maintains Buy on Cue Biopharma, Mainta...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Cue Bioph...
Benzinga Newsdesk
Monday, April 08, 2024
Cue Biopharma Q1 EPS $(0.28) Misses $(0.27) E...
Benzinga Newsdesk
Wednesday, April 03, 2024
Piper Sandler Reiterates Overweight on Cue Bi...
Benzinga Newsdesk
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Cue Biopharma shares are trading higher after...
Benzinga Newsdesk
Jefferies Initiates Coverage On Cue Biopharma...
Benzinga Newsdesk
Monday, January 01, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, November 09, 2023
Cue Biopharma Q3 EPS $(0.24) Beats $(0.34) Es...
Benzinga Newsdesk
Monday, November 06, 2023
Piper Sandler Maintains Overweight on Cue Bio...
Benzinga Newsdesk
Friday, November 03, 2023
Cue Biopharma Presents New Data From Phase 1 ...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, September 26, 2023
Cue Biopharma Has Completed Patient Enrollmen...
Benzinga Newsdesk
Wednesday, August 30, 2023
Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
Wednesday, August 09, 2023
Cue Biopharma Q2 EPS $(0.29) Beats $(0.30) Es...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Wednesday, July 26, 2023
Cue Biopharma SVP Awarded $284K Worth of Stock Options
Benzinga Insights
Chief Executive Officer at Cue Biopharma Acquires Company Stock Options Worth 450,000 Shares
Benzinga Insights
Cue Biopharma Chief Medical Officer Awarded $312K Worth of Stock Options
Benzinga Insights
Cue Biopharma Chief Financial Officer Awarded $428K Worth of Stock Options
Benzinga Insights
Monday, June 26, 2023
Oppenheimer Assumes Cue Biopharma at Outperfo...
Benzinga Newsdesk
Thursday, June 15, 2023
Where Cue Biopharma Stands With Analysts
Benzinga Insights
Stifel Reiterates Buy on Cue Biopharma, Maint...
Benzinga Newsdesk
Monday, May 15, 2023
JMP Securities Reiterates Outperform on Cue B...
Benzinga Newsdesk
Wednesday, March 22, 2023
Cue Biopharma Earnings Perspective: Return On Capital Employed
Benzinga Insights
Stifel Maintains Buy on Cue Biopharma, Lowers...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Cue Biop...
Benzinga Newsdesk
Tuesday, March 21, 2023
Cue Biopharma Q4 EPS $(0.37) Misses $(0.31) E...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2023
Benzinga Insights
Monday, March 20, 2023
Cue Biopharma's Earnings Outlook
Benzinga Insights
Wednesday, February 22, 2023
Cue Biopharma Enters Into A Strategic Collaboration And Option Agreement With Ono Pharmaceutical For CUE-401
Happy Mohamed
Monday, November 21, 2022
Piper Sandler Initiates Coverage On Cue Bioph...
Benzinga Newsdesk
Monday, November 14, 2022
Cue Biopharma Q3 EPS $(0.31) Up From $(0.41) ...
Benzinga Newsdesk
Thursday, November 10, 2022
Cue Biopharma Presents New Data From Ongoing ...
Benzinga Newsdesk
Monday, October 24, 2022
Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket
Lisa Levin
Tuesday, October 04, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Cue Biopharma Granted FDA Fast Track Designat...
Benzinga Newsdesk
Monday, October 03, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, September 01, 2022
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, August 24, 2022
Oppenheimer Maintains Outperform on Cue Bioph...
Benzinga Newsdesk
Monday, August 22, 2022
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Ragothaman Srinivasan
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
Ragothaman Srinivasan
Cue Biopharma Doses First Patient In Phase 1 ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
